10 recruiting, 6 not yet recruiting, 6 unknown, 1 active not recruiting. 13 Phase 2, 4 Not applicable, 1 Phase 1, 1 Phase 3.
Follow Thymic epithelial tumor: new trials by email Literature Review of Thymic epithelial tumor trials Research Report on Thymic epithelial tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors Hypofractionated Adjuvant Proton Therapy, Hypofractionated Adjuvant Photon Radiation Therapy - Thymus Neoplasms, Thymic Epithelial Tumor | Not applicable | Not yet recruiting | National Taiwan University Hospital | 69 | 2026-08-01 | 2026-07-16 |
| Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors Postoperative hypo-fractionated radiotherapy - Thymic Epithelial Tumor | Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 49 | 2026-07-14 | 2026-07-10 |
| Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma Cyclophosphamide, Fludarabine, EB-CAR30-NK - B2 Thymoma, Thymic Carcinoma | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 36 | 2026-03-02 | 2026-05-20 |
| 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors Cyclophosphamide, Doxorubicin, and Cisplatin (CAP), nab-Paclitaxel and Carboplatin - Thymoma and Thymic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 116 | 2026-03-01 | 2026-03-11 |
| Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) Surgery alone, Surgery+HITOC - Thymic Epithelial Tumor | Not applicable | Not yet recruiting | Shanghai Zhongshan Hospital | 202 | 2026-02-01 | 2026-02-06 |
| Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis Patients with thymic epithelial tumors with pleural metastasis or recurrence who undergo extended thymectomy with electrocautery resection of pleural metastases followed by two cycles of hyperthermic, Hyperthermic Intrathoracic Chemotherapy (HITHOC) - Thymic Epithelial Tumor, Thymoma | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 70 | 2026-02-01 | 2026-02-05 | |
| Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor Carbon ion radiotherapy, combined with platinum-based regimen - Thymic Epithelial Tumor, Radiotherapy Side Effect | Phase 2 | Recruiting | Jian Chen | 48 | 2025-07-01 | 2025-06-13 |
| RATT Vs. VATT for Early-stage TETs RATT, VATT - Thymic Epithelial Tumor | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 100 | 2024-11-01 | 2024-10-30 |
| Hypofractionated Radiotherapy for Thymic Epithelial Tumors Hypofractionated Radiation Therapy - Thymoma and Thymic Carcinoma, Thymoma | Not applicable | Recruiting | Rongrong Zhou | 100 | 2024-10-01 | 2024-11-18 |
| The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor Proton radiotherapy, combined platinum based chemotherapy - Thymus Epithelial Tumor, Proton Radiotherapy | Phase 2 | Recruiting | Jian Chen | 55 | 2024-05-06 | 2025-06-13 |
| Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor Rivoceranib - Thymic Epithelial Tumor | Phase 2 | Not yet recruiting | Samsung Medical Center | 40 | 2024-05-01 | 2024-04-09 |
| Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors Artificial Intelligence Diagnostics, Recurrence Prediction Tool - Thymic Epithelial Tumor, Thymic Carcinoma | Recruiting | Erasmus Medical Center | 1020 | 2023-08-01 | 2024-03-27 | |
| Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence HITOC - Thymic Epithelial Tumor | Not applicable | Unknown | Shanghai Zhongshan Hospital | 37 | 2022-10-01 | 2022-09-19 |
| PT-112 in Subjects With Thymoma and Thymic Carcinoma PT-112 - Thymic Epithelial Tumor, Recurrent Thymoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 53 | 2022-04-06 | 2026-10-16 |
| Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor Toripalimab + Chemotherapy - Thymic Epithelial Tumor | Phase 2 | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 15 | 2021-01-31 | 2023-04-04 |
| Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma M7824 - Thymic Epithelial Tumor, Recurrent Thymoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 9 | 2020-12-26 | 2026-10-16 |
| Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors rhGM-CSF，Peginterferon alfa-b2，radiation - Thymic Epithelial Tumor | Phase 2 | Unknown | Shanghai Cancer Hospital, China | 65 | 2020-12-01 | 2020-08-18 |
| neoadjuvant_thymic Epithelial Tumor pembrolizumab, Radiation - Thymic Epithelial Tumor | Phase 2 | Unknown | Samsung Medical Center | 40 | 2019-04-29 | 2021-03-22 |
| Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging Thymic Epithelial Tumor | Unknown | Tang-Du Hospital | 60 | 2017-07-31 | 2017-07-18 | |
| Molecular Analysis and Treatment Options of Thymic Malignancies Chemotherapy - Thymic Epithelial Tumor, Thymic Carcinoma | Recruiting | Shanghai Chest Hospital | 500 | 2016-01-01 | 2025-05-22 |
Showing 20 of 24. Sign in to see all of them.
Thymoma (10) · Thymus Neoplasms (5) · Radiation Injuries (2) · Esophageal Squamous Cell Carcinoma (1) · Goiter, Substernal (1) · Lymphoma (1) · Mediastinal Cyst (1) · Mediastinal Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Neurilemmoma (1) · Peripheral Nervous System Diseases (1) · Teratoma (1)
Neoplasms (12) · Neoplasms by Histologic Type (12) · Hemic and Lymphatic Diseases (11) · Lymphatic Diseases (11) · Neoplasms by Site (11) · Neoplasms, Complex and Mixed (10) · Thoracic Neoplasms (10) · Thymus Neoplasms (5) · Mediastinal Diseases (2) · Respiratory Tract Diseases (2) · Thoracic Diseases (2) · Wounds and Injuries (2) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Cysts (1)
Cyclophosphamide (2) · Drug Therapy (2) · 130-nm albumin-bound paclitaxel (1) · AP 1903 reagent (1) · Carboplatin (1) · Cisplatin (1) · Doxorubicin (1) · Heavy Ion Radiotherapy (1) · Immunotherapy (1) · Radiation (1) · Surgical Procedures, Operative (1) · TP protocol (1) · apatinib (1) · fludarabine (1) · pembrolizumab (1)
Shanghai Zhongshan Hospital (3) · Jian Chen (2) · National Cancer Institute (NCI) (2) · Samsung Medical Center (2) · Shanghai Cancer Hospital, China (2) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (2) · Beijing Biotech (1) · Erasmus Medical Center (1) · Intergroupe Francophone de Cancerologie Thoracique (1) · Korean Cancer Study Group (1) · National Taiwan University Hospital (1) · Peking Union Medical College Hospital (1) · Rongrong Zhou (1) · Shanghai Chest Hospital (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
China (14) · South Korea (3) · United States (2) · France (1) · Netherlands (1) · Taiwan (1)
Arun Rajan, M.D. (2) · Jingfang Mao, PHD (2) · Dae Seog Heo, MD, PhD (1) · Fan Jiang, MD, PhD (1) · Feng-Ming Hsu, M.D., Ph.D. (1) · Shanqing Li, Prof. (1) · Wencheng Zhang, M.D. (1)
PMID 23131309, PMID 24630641, PMID 26534878, PMID 27237035, PMID 27720478, PMID 28774861, PMID 30138763, PMID 30512890, PMID 31413632, PMID 31827799, PMID 31917264, PMID 33309329, PMID 33316754, PMID 33629132, PMID 33736940, PMID 34393061, PMID 34455064, PMID 34965496, PMID 38410567, PMID 40441770, PMID 40467556, PMID 41109992